Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Danielle E. Arnold"'
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Recently, primary immune regulatory disorders have been described as a subset of inborn errors of immunity that are dominated by immune mediated pathology. As the pathophysiology of disease is elucidated, use of biologic modifiers have been increasin
Externí odkaz:
https://doaj.org/article/a7144cf5961d4bdcacc95d4f96ab7f8e
Autor:
Eyal Grunebaum, Danielle E. Arnold, Brent Logan, Suhag Parikh, Rebecca A. Marsh, Linda M. Griffith, Kanwaldeep Mallhi, Deepak Chellapandian, Stephanie Si Lim, Christin L. Deal, Luis Murguía-Favela, Talal I. Mousallem, Prof. Vinod K. Prasad, Pierre Teira, Fabien Touzot, Nancy J. Bunin, Jennifer R. Heimall, Lauri M. Burroughs, Malika Kapadia, Susan Prockop, Sharat Chandra, Shanmuganathan Chandrakasan, Sonali Chaudhury, Larisa Broglie, Richard J. O’Reilly, Blachy J. Dávila Saldaña, Edo Schaefer, Hey Chong, Jeffrey J. Bednarski, Ahmad Rayes, Kenneth DeSantes, Donald B. Kohn, Luigi D. Notarangelo, Sung-Yun Pai, Jennifer Puck, Troy Torgerson, Morton J. Cowan, Christopher C. Dvorak, Lisa Forbes Satter, Elie Haddad, Michael Pulsipher, Harry L. Malech, Elizabeth M. Kang, Jennifer W. Leiding
Publikováno v:
Transplantation and Cellular Therapy. 29:S289-S290
Autor:
Emma C. Morris, Ashok Kumar, Justin T. Wahlstrom, Danielle E. Arnold, Connor Wakefield, Tim Brettig, Michael B. Jordan, Stephan Ehl, Theresa Cole, Jennifer Heimall, Małgorzata Salamonowicz, Michael H. Albert, Carsten Speckmann, Austen Worth, Rofida Nofal, Claire Booth, Nancy Bunin, Rebecca A. Marsh, Sharon Choo, Kai Lehmberg, Kanchan Rao, Katharina Wustrau
Publikováno v:
Journal of Clinical Immunology
X-linked inhibitor of apoptosis (XIAP) deficiency is an inherited primary immunodeficiency characterized by chronic inflammasome overactivity and associated with hemophagocytic lymphohistiocytosis (HLH) and inflammatory bowel disease (IBD). Allogenei
Autor:
Danielle E. Arnold, Suhag Parikh, Brent Logan, Rebecca Marsh, Linda M. Griffith, Ruizhe Wu, Kanwaldeep Mallhi, Deepak Chellapandian, Stephanie Si, Eyal Grunebaum, Larisa Broglie, Vinod K. Prasad, Jennifer Heimall, Nancy J. Bunin, Pierre Teira, Fabien Touzot, Lauri M. Burroughs, Aleksandra Petrovic, Jack J. Bleesing, Sharat Chandra, Neena Kapoor, Jasmeen Dara, Morna Dorsey, Olatundun Williams, Malika Kapadia, Jeffrey Bednarski, Ahmad Rayes, Karin Chen, Hey Chong, Geoff D.E. Cuvelier, Lisa R. Forbes, Caridad Martinez, Mark T. Vander Lugt, Lolie C. Yu, Shanmuganathan Chandrakasan, Avni Joshi, Susan E. Prockop, Blachy J. Davila Saldana, Victor Aquino, Christen L. Ebens, Lisa Madden, Kenneth DeSantes, Jordan Milner, Hemalatha G. Rangarajan, Ami J Shah, Alfred P. Gillio, Alan P. Knutsen, Holly K. Miller, Theodore B. Moore, Nicola Wright, Morton J. Cowan, Christopher C. Dvorak, Elie Haddad, Donald B. Kohn, Luigi D. Notarangelo, Sung-Yun Pai, Jennifer Puck, Mike A. Pulsipher, Troy Torgerson, Harry L. Malech, Elizabeth M. Kang, Jennifer W. Leiding
Publikováno v:
Transplantation and Cellular Therapy. 28:S101-S103
Autor:
Lisa Neumeier, Kelly McIntosh, Adam S. Nelson, Adam Lane, Min Dong, Tsuyoshi Fukuda, Danielle E. Arnold, Parinda A. Mehta, Federica Achini, Sharat Chandra, Arjan C. Lankester, Alexander A. Vinks, Ashley Teusink-Cross, Chie Emoto, Rebecca A. Marsh, Michael B. Jordan, Kasiani C. Myers, Stella M. Davies
Publikováno v:
Bone Marrow Transplantation. SPRINGERNATURE
Bone Marrow Transplantation
Bone Marrow Transplantation
Alemtuzumab is used as part of reduced-intensity and reduced-toxicity transplant conditioning regimens for nonmalignant diseases. Prior studies identified an ideal target concentration range of 0.15-0.6 mcg/mL at day 0. However, only 24% of patients
Autor:
Hey J Chong, Benjamin T Prince, Danielle E. Arnold, Kelli W. Williams, Wilfredo Cosme-Blanco, Margaret Redmond, Nicholas L. Hartog, Steven M. Holland, Beth K Thielen, Erinn S. Kellner
Publikováno v:
Pediatric Health, Medicine and Therapeutics. 11:257-268
Chronic granulomatous disease (CGD) is a rare but serious primary immunodeficiency with varying prevalence and rates of X-linked and autosomal recessive disease worldwide. Functional defects in the phagocyte nicotinamide adenine dinucleotide phosphat
Autor:
Nadine Van Roy, Kirsi Jahnukainen, Danielle E. Arnold, Sioban Keel, Katherine R. Calvo, Gudrun Göhring, Cristina Mecucci, Charlotte M. Niemeyer, Joelle Tchinda, Alison A. Bertuch, Jochen Buechner, Dennis D. Hickstein, Olga Haus, Peter Nöllke, Shlomit Barzilai-Birenboim, Courtney D. DiNardo, Martin Čermák, Helena Alaiz, Ayami Yoshimi, Hiroto Inaba, Sara Lewis, Steven M. Holland, Shinsuke Hirabayashi, Brigitte Schlegelberger, Victor B Pastor, Dominik Turkiewicz, Emilia J Kozyra, Hajnalka Andrikovics, Amy P. Hsu, Mark D. Fleming, David R. Betts, Henrik Hasle, Karin Nebral, Masahiro Onozawa, Valerie de Haas, Jan Stary, José Cervera, Francesco Pasquali, Akiko Shimamura, Kalliopi N. Manola, Michael Dworzak, Kiran Tawana, Zuzana Zemanova, Marcin W. Wlodarski, Shaohua Lei, H. Berna Beverloo, Brigitte Strahm
Publikováno v:
Kozyra, E J, Göhring, G, Hickstein, D D, Calvo, K R, DiNardo, C D, Dworzak, M, de Haas, V, Starý, J, Hasle, H, Shimamura, A, Fleming, M D, Inaba, H, Lewis, S, Hsu, A P, Holland, S M, Arnold, D E, Mecucci, C, Keel, S B, Bertuch, A A, Tawana, K, Barzilai, S, Hirabayashi, S, Onozawa, M, Lei, S, Alaiz, H, Andrikovics, H, Betts, D, Beverloo, B H, Buechner, J, Čermák, M, Cervera, J, Haus, O, Jahnukainen, K, Manola, K N, Nebral, K, Pasquali, F, Tchinda, J, Turkiewicz, D, Van Roy, N, Zemanova, Z, Pastor, V B, Strahm, B, Noellke, P, Niemeyer, C M, Schlegelberger, B, Yoshimi, A & Wlodarski, M W 2021, ' Association of unbalanced translocation der(1;7) with germline GATA2 mutations ', Blood, vol. 138, no. 23, pp. 2441-2445 . https://doi.org/10.1182/blood.2021012781
Blood, 138(23), 2441-2445. American Society of Hematology
Blood
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood, 138(23), 2441-2445. American Society of Hematology
Blood
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac915d144b3e5e29067d37c55b8eaea0
https://pure.au.dk/ws/files/274410748/Primary_cytotoxic_T_cell_lymphomas_harbor_recurrent_targetable_alterations_in_the_JAK_STAT_pathway.pdf
https://pure.au.dk/ws/files/274410748/Primary_cytotoxic_T_cell_lymphomas_harbor_recurrent_targetable_alterations_in_the_JAK_STAT_pathway.pdf
Autor:
Danielle E. Arnold, Deepak Chellapandian, Suhag Parikh, Kanwaldeep Mallhi, Rebecca A. Marsh, Jennifer R. Heimall, Debra Grossman, Maria Chitty-Lopez, Luis Murguia-Favela, Andrew R. Gennery, Farid Boulad, Erin Arbuckle, Morton J. Cowan, Christopher C. Dvorak, Linda M. Griffith, Elie Haddad, Donald B. Kohn, Luigi D. Notarangelo, Sung-Yun Pai, Jennifer M. Puck, Michael A. Pulsipher, Troy Torgerson, Elizabeth M. Kang, Harry L. Malech, Jennifer W. Leiding
Publikováno v:
Journal of clinical immunology, vol 42, iss 5
Granulocyte transfusions are sometimes used as adjunctive therapy for the treatment of infection in patients with chronic granulomatous disease (CGD). However, granulocyte transfusions can be associated with a high rate of alloimmunization, and their
Autor:
Min Dong, Parinda A. Mehta, Tsuyoshi Fukuda, Alexander A. Vinks, Danielle E. Arnold, Chie Emoto, Rebecca A. Marsh
Publikováno v:
British journal of clinical pharmacologyREFERENCES. 88(1)
Aim Alemtuzumab is a lymphodepleting monoclonal antibody utilized in conditioning regimens for allogeneic hematopoietic cell transplantation (HCT). A recently proposed therapeutic range of 0.15-0.6 μg/mL on the day of transplantation is associated w
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Recently, primary immune regulatory disorders have been described as a subset of inborn errors of immunity that are dominated by immune mediated pathology. As the pathophysiology of disease is elucidated, use of biologic modifiers have been increasin